You are here

Article Text

Article menu
Download PDFPDF
Letter
Gamma knife radiosurgery for choroidal haemangiomas with extensive exudative retinal detachment
  1. W K Song1,
  2. S H Byeon2,
  3. S S Kim1,
  4. O W Kwon2,
  5. S C Lee2
  1. 1
    Department of Ophthalmology, Yonsei University College of Medicine, Yongdong Severance Hospital, Seoul, Republic of Korea
  2. 2
    The Institute of Vision Research, Department of Ophthalmology, Yonsei University College of Medicine, Seoul, Republic of Korea
  1. Dr S C Lee, Department of Ophthalmology, Yonsei University College of Medicine, 134 Shinchon-dong, Seodaemun-ku, 120-752, Seoul, Republic of Korea; sunglee{at}yuhs.ac

https://doi.org/10.1136/bjo.2008.151316

Statistics from Altmetric.com

    Request Permissions

    If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

    Choroidal haemangioma (CH) is a benign vascular tumour. CH that produces visual symptoms due to subretinal fluid has been treated with cryotherapy, diathermy, photocoagulation, photodynamic therapy (PDT), transpupillary thermotherapy (TTT) and various radiation therapies. However, extensive exudative retinal detachment is challenging to treat. Previous reports utilising gamma knife radiosurgery (GKR) in CHs are scarce.1 2 We present our results of GKR on CH with extensive exudative retinal detachment (RD).

    Methods

    The medical records of three consecutive CH patients with decreased visual acuity due to extensive exudative RD involving more than two quadrants, treated with GKR, were retrospectively reviewed. GKR was performed as a secondary treatment after the aggravation of exudative RD following a single session of transpupillary thermotherapy (TTT).

    Results

    Table 1 lists the basic characteristics of the patients. The mean age of the patients was 38.3 years …

    View Full Text

    Footnotes

    • Competing interests: None.

    • Ethics approval: Ethics approval was provided by the Institutional Review Board of Yonsei Univeristy Hospital.

    • Patient consent: Obtained.